Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

His leadership will be instrumental as we navigate the next phase of growth," said John Forsyth, President and CEO of Cirrus Logic. "I'm excited to collaborate with Jeff as we strengthen our position ...

EDMONTON – Alberta’s government says it has dismantled the board of Alberta Health Services — for the second time in nearly as many years — and appointed a high-ranking bureaucrat as ...

U.N. officials vowed Thursday that the agency would continue to deliver services in the Palestinian territories for as long as possible.

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

Baxter International Inc. (BAX), a healthcare company, Monday announced the appointment of Lead Independent Director Brent Shafer as ...

The Board of Directors of Hammond-Henry Hospital in Geneseo have announced the appointment of a new Interim CEO Bradley ...

Interim HealthCare is excited to announce the release of Fullness of Joy: One Hundred Devotions to Bring You Into God’s Presence by Elizabeth “Libby” Rice Handford. This heartfelt collection ...

Aster DM Healthcare reported a strong financial performance for the third quarter (Q3) and nine months (9M) of FY25, driven ...

Profit rose in the fourth quarter compared to the same period of the previous year for French banking giant BNP Paribas. BNP ...

Paul Mango, who helped launch health system-backed Longitude Health last year, died last week. Brett Moraski will serve as ...